ES8R
TEAS SECTION 8 RECEIVED
07/08/2026
Back to search
Official data from USPTO
3D TUMORSPHERE MEDIUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
3D TUMORSPHERE MEDIUM
ST13
US500000088382241Class
1, 5, 10
Filing
88382241
Registration
6143842
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
07/09/2026
Trademark type
Word
Nice classes
1, 5, 10
Filing date
04/11/2019
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Drawing code
4
Owner type
27
Owner location
HEIDELBERG, DE
Examiner
SHINN, LAUREN DONGMI
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PROMOCELL GMBH
PromoCell bioscience alive GmbH Biomedizinische Produkte
Representatives
Shoko Naruo Thompson Coburn LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
basesraw materialsauxiliaries and active ingredientsall being types of chemicals for use in industry and science for producing chemicalbiochemicalbiological and cell biological preparations; media for cell culture for use in the biotechnological industry and for non-medical research laboratories; biological preparation for use in cell cultures other than for medical or veterinary use; chemical products used in industrychemicals for use in in vitro research and development applications; biochemicals used in industryin in vitro research and development applications; biological preparations for use in industry; cytobiological preparations for use in industry; base materialsraw materialsauxiliary materials and active substancesall being types of chemicals for use in manufacturing biomedical and medical preparations
Class 5
medicines for regenerative purposescancercardio vascular diseasesrespiratory diseasesdermatological diseases; pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; sanitary preparations for medical use; dietetic foodstuffs adapted for medical use; foodstuff supplements adapted for medical use; plasters for medical use and bandageswadding and gauze for dressings; chemicalbiochemicalbiologicalcellular biological preparations for medical and biomedical science purposescell and stem cell applicationsregenerative solutions and for the treatment of cancerdermatological diseasesrespiratory diseasescardio vascular diseases; cell cultures for cultivating human and animal cellsfor medical purposes
Class 10
cell culture systems for medical usecell culture chambers used for human and animal cells
Publications
History of USPTO decisions and trademark events.
28 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/01/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/24/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/01/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/28/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/09/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/29/2020
GNFR
FINAL REFUSAL E-MAILED
01/29/2020
CNFR
FINAL REFUSAL WRITTEN
01/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/26/2019
GNRT
NON-FINAL ACTION E-MAILED
06/26/2019
CNRT
NON-FINAL ACTION WRITTEN
06/26/2019
DOCK
ASSIGNED TO EXAMINER
06/20/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/30/2019
ALIE
ASSIGNED TO LIE
05/30/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/29/2019
NWAP
NEW APPLICATION ENTERED
04/15/2019
Continuous trademark protection
Get notified about every new filing that threatens 3D TUMORSPHERE MEDIUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.